PD-1/PD-L1 blockade enhances the efficacy of SA-GM-CSF surface-modified tumor vaccine in prostate cancer

Shi, XJ; Zhang, XJ; Li, JL; Zhao, HF; Mo, LJ; Shi, XH; Hu, ZM; Gao, JM; Tan, WL

Tan, WL (reprint author), Southern Med Univ, Nanfang Hosp, Dept Urol, Guangzhou 510515, Guangdong, Peoples R China.

CANCER LETTERS, 2017; 406 ( ): 27

Abstract

Program death receptor-1 (PD-1)/program death ligand 1 (PD-L1) signaling plays an important role in tumor adaptive immune resistance. The streptavidin......

Full Text Link